These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30430940

  • 21. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():304-13. PubMed ID: 24184687
    [Abstract] [Full Text] [Related]

  • 22. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
    Almulla AF, Thipakorn Y, Tunvirachaisakul C, Maes M.
    Autism Res; 2023 Dec 03; 16(12):2302-2315. PubMed ID: 37909397
    [Abstract] [Full Text] [Related]

  • 23. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
    Souza LC, Jesse CR, Antunes MS, Ruff JR, de Oliveira Espinosa D, Gomes NS, Donato F, Giacomeli R, Boeira SP.
    Brain Behav Immun; 2016 Aug 03; 56():363-77. PubMed ID: 26965653
    [Abstract] [Full Text] [Related]

  • 24. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
    Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Ormstad H, Anderson G, Maes M.
    Mol Neurobiol; 2018 Feb 03; 55(2):1524-1536. PubMed ID: 28181189
    [Abstract] [Full Text] [Related]

  • 25. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
    Schefold JC, Zeden JP, Pschowski R, Hammoud B, Fotopoulou C, Hasper D, Fusch G, Von Haehling S, Volk HD, Meisel C, Schütt C, Reinke P.
    Scand J Infect Dis; 2010 Mar 03; 42(3):164-71. PubMed ID: 19958238
    [Abstract] [Full Text] [Related]

  • 26. Inflammation, serotonin and major depression.
    Catena-Dell'Osso M, Rotella F, Dell'Osso A, Fagiolini A, Marazziti D.
    Curr Drug Targets; 2013 May 01; 14(5):571-7. PubMed ID: 23531160
    [Abstract] [Full Text] [Related]

  • 27. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
    Ramírez LA, Pérez-Padilla EA, García-Oscos F, Salgado H, Atzori M, Pineda JC.
    Biomedica; 2018 Sep 01; 38(3):437-450. PubMed ID: 30335249
    [Abstract] [Full Text] [Related]

  • 28. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N, Schwarz MJ.
    Mol Psychiatry; 2007 Nov 01; 12(11):988-1000. PubMed ID: 17457312
    [Abstract] [Full Text] [Related]

  • 29. Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.
    Meier MA, Ottiger M, Vögeli A, Steuer C, Bernasconi L, Thomann R, Christ-Crain M, Henzen C, Hoess C, Zimmerli W, Huber A, Mueller B, Schuetz P.
    Clin Chem Lab Med; 2017 Jun 27; 55(7):1060-1069. PubMed ID: 28076309
    [Abstract] [Full Text] [Related]

  • 30. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.
    Souza LC, Jesse CR, de Gomes MG, Del Fabbro L, Goes ATR, Donato F, Boeira SP.
    Neurochem Res; 2017 Oct 27; 42(10):2982-2995. PubMed ID: 28631232
    [Abstract] [Full Text] [Related]

  • 31. A review of the immunomodulatory role of dietary tryptophan in livestock and poultry.
    Bai M, Liu H, Xu K, Oso AO, Wu X, Liu G, Tossou MC, Al-Dhabi NA, Duraipandiyan V, Xi Q, Yin Y.
    Amino Acids; 2017 Jan 27; 49(1):67-74. PubMed ID: 27778165
    [Abstract] [Full Text] [Related]

  • 32. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
    Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T.
    Stress; 2008 May 27; 11(3):198-209. PubMed ID: 18465467
    [Abstract] [Full Text] [Related]

  • 33. Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase.
    Souza LC, Jesse CR, de Gomes MG, Viana CE, Mattos E, Silva NC, Boeira SP.
    Neurotox Res; 2017 May 27; 31(4):464-477. PubMed ID: 28155213
    [Abstract] [Full Text] [Related]

  • 34. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH.
    Int J Biochem Cell Biol; 2009 Mar 27; 41(3):467-71. PubMed ID: 18282734
    [Abstract] [Full Text] [Related]

  • 35. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.
    Nephrol Dial Transplant; 2009 Jun 27; 24(6):1901-8. PubMed ID: 19155537
    [Abstract] [Full Text] [Related]

  • 36. Association between increased tryptophan degradation and depression in cancer patients.
    Kurz K, Schroecksnadel S, Weiss G, Fuchs D.
    Curr Opin Clin Nutr Metab Care; 2011 Jan 27; 14(1):49-56. PubMed ID: 21076293
    [Abstract] [Full Text] [Related]

  • 37. Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.
    Meier MA, Ottiger M, Vögeli A, Steuer C, Bernasconi L, Thomann R, Christ-Crain M, Henzen C, Hoess C, Zimmerli W, Huber A, Mueller B, Schuetz P.
    Lung; 2017 Jun 27; 195(3):303-311. PubMed ID: 28434116
    [Abstract] [Full Text] [Related]

  • 38. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
    Strasser B, Becker K, Fuchs D, Gostner JM.
    Neuropharmacology; 2017 Jan 27; 112(Pt B):286-296. PubMed ID: 26924709
    [Abstract] [Full Text] [Related]

  • 39. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M.
    CNS Neurol Disord Drug Targets; 2019 Jan 27; 18(2):124-140. PubMed ID: 30451122
    [Abstract] [Full Text] [Related]

  • 40. Don't panic. A guide to tryptophan depletion with disorder-specific anxiety provocation.
    Hood SD, Bell CJ, Argyropoulos SV, Nutt DJ.
    J Psychopharmacol; 2016 Nov 27; 30(11):1137-1140. PubMed ID: 27329165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.